Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy

Pharmacology and Therapeutics

Volumn 111, Issue 2, 2006, Pages 476-494

  Kirkham, Paul ^a,b   Rahman, Irfan ^a,b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Asthma; Chronic obstructive pulmonary disease; Corticosteroids; Inflammation; Lungs; Reactive oxygen species

Indexed keywords

3,4 DIHYDRO 4,4 DIMETHYL 1,3 BENZOSELENAZINE; 4,6 DI TERT BUTYL 2,3 DIHYDRO 5 HYDROXY 2,2 DIPENTYLBENZOFURAN; 5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ACETYLCYSTEINE; AEOL 10113; AEOL 10150; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; AZULENYL NITRONE; BETA CAROTENE; CORTICOSTEROID; DISUFENTON SODIUM; EBSELEN; ENZYME INHIBITOR; ERDOSTEINE; GLUTATHIONE; M 40401; M 40419; MANGANESE DERIVATIVE; MANGANESE N,N' ETHYLENEBIS(3 METHOXYSALICYLIDENEAMINE); MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); MOL 294; N ACYSTELYN; NITRONE DERIVATIVE; PNRI 299; REACTIVE OXYGEN METABOLITE; SELENIUM; STEROID; THIOL DERIVATIVE; THIONEINE; U 937; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACETYLATION; ANTIOXIDANT ACTIVITY; ASTHMA; BRONCHUS HYPERREACTIVITY; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DEACETYLATION; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG SCREENING; ENZYME LOCALIZATION; HUMAN; INFLAMMATION; LUNG CANCER; MEMBRANE PERMEABILITY; MOLECULAR BIOLOGY; NITRATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; SPIN TRAPPING; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; ASTHMA; HUMANS; LUNG; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REACTIVE OXYGEN SPECIES;

EID: 33744832661     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.10.015     Document Type: Review

References (234)

1. Aaron S.D., Angel J.B., Lunau M., Wright K., Fex C., Le Saux N., et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 349-355
2. Adam L., Bouvier M., and Jones T.L. Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling. J Biol Chem 274 (1999) 26337-26343
3. Adler V., Yin Z., Tew K.D., and Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18 (1999) 6104-6111
4. Agosti J.M., Altman L.C., Ayars G.H., Loegering D.A., Gleich G.J., and Klebanoff S.J. The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J Allergy Clin Immunol 79 (1987) 496-504
5. Allam M.F., and Lucane R.A. Selenium supplementation for asthma. Cochrane Database Syst Rev CD003538 (2004)
6. Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6 (1993) 1368-1370
7. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) S77-S121
8. Anderson R. Assessment of the roles of vitamin c, vitamin e, and beta-carotene in the modulation of oxidant stress mediated by cigarette smoke-activated phagocytes. Am J Clin Nutr 53 (1991) 358S-361S
9. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59 (2000) 95-104
10. Antczak A., Nowak D., Shariati B., Krol M., Piasecka G., and Kurmanowska Z. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 10 (1997) 1235-1241
11. Antonicelli F., Parmentier M., Drost E.M., Hirani N., Rahman I., Donaldson K., et al. Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells. Free Radic Biol Med 32 (2002) 492-502
12. Antonicelli F., Brown D., Parmentier M., Drost E.M., Hirani N., Rahman I., et al. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant nacystelyn. Am J Physiol Lung Cell Mol Physiol 286 (2004) L1319-L1327
13. App E.M., Baran D., Dab I., Malfroot A., Coffiner M., Vanderbist F., et al. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized nacystelyn in cystic fibrosis. Eur Respir J 19 (2002) 294-302
14. Arts I.C., and Hollman P.C. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81 (2005) 317S-325S
15. Aruoma O.I., Whiteman M., England T.G., and Halliwell B. Antioxidant action of ergothioneine: assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 231 (1997) 389-391
16. Barnes, P. J. (2004). Alveolar macrophages in chronic obstructive pulmonary disease (COPD) [Sarreguemines, France, Print]. Cell Mol Biol, 50(Suppl.), OL627-OL637 (Ref Type: Journal (Full)).
17. Barnes P.J. Mechanisms in COPD: differences from asthma. Chest 117 (2000) 10S-14S
18. Becker D.A. Diagnostic and therapeutic applications of azulenyl nitrone spin traps. Cell Mol Life Sci 56 (1999) 626-633
19. Becker D.A., Ley J.J., Echegoyen L., and Alvarado R. Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants. J Am Chem Soc 124 (2002) 4678-4684
20. Beckman D.L., Mehta P., Hanks V., Rowan W.H., and Liu L. Effects of peroxynitrite on pulmonary edema and the oxidative state. Exp Lung Res 26 (2000) 349-359
21. Birrell M.A., McCluskie K., Wong S., Donnelly L.E., Barnes P.J., and Belvisi M.G. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J 19 (2005) 840-841
22. Biswas S.K., McClure D., Jimenez L.A., Megson I.L., and Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7 (2005) 32-41
23. Borok Z., Buhl R., Grimes G.J., Bokser A.D., Hubbard R.C., Holroyd K.J., et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338 (1991) 215-216
24. Bottle S.E., and Micallef A.S. Synthesis and EPR spin trapping properties of a new isoindole-based nitrone: 1,1,3-trimethylisoindole N-oxide (TMINO). Org Biomol Chem 1 (2003) 2581-2584
25. Bridgeman M.M., Marsden M., MacNee W., Flenley D.C., and Ryle A.P. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine. Thorax 46 (1991) 39-42
26. Bridgeman M.M., Marsden M., Selby C., Morrison D., and MacNee W. Effect of N-acetylcysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 49 (1994) 670-675
27. British Thoracic Society. Bts guidelines for the management of chronic obstructive pulmonary disease. The COPD guidelines group of the standards of care committee of the BTS. Thorax 52 Suppl. 5 (1997) S1-S28
28. Britton J.R., Pavord I.D., Richards K.A., Knox A.J., Wisniewski A.F., Lewis S.A., et al. Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med 151 (1995) 1383-1387
29. Brown K.M., and Arthur J.R. Selenium, selenoproteins and human health: a review. Public Health Nutr 4 (2001) 593-599
30. Bucca C., Rolla G., Arossa W., Caria E., Elia C., Nebiolo F., et al. Effect of ascorbic acid on increased bronchial responsiveness during upper airway infection. Respiration 55 (1989) 214-219
31. Calhoun W.J., Reed H.E., Moest D.R., and Stevens C.A. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis 145 (1992) 317-325
32. Cantin A.M., North S.L., Hubbard R.C., and Crystal R.G. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63 (1987) 152-157
33. Chabrier P.E., Auguet M., Spinnewyn B., Auvin S., Cornet S., Demerle-Pallardy C., et al. BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy. Proc Natl Acad Sci U S A 96 (1999) 10824-10829
34. Chalmers G.W., Macleod K.J., Little S.A., Thomson L.J., McSharry C.P., and Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 57 (2002) 226-230
35. Chang L.Y., and Crapo J.D. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic Biol Med 33 (2002) 379-386
36. Chatterjee P.K., Patel N.S., Kvale E.O., Brown P.A., Stewart K.N., Mota-Filipe H., et al. EUK-134 reduces renal dysfunction and injury caused by oxidative and nitrosative stress of the kidney. Am J Nephrol 24 (2004) 165-177
37. Chen L., Fischle W., Verdin E., and Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293 (2001) 1653-1657
38. Church D.F., and Pryor W.A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64 (1985) 111-126
39. Clausen J. The influence of selenium and vitamin E on the enhanced respiratory burst reaction in smokers. Biol Trace Elem Res 31 (1991) 281-291
40. Cluzel M., Damon M., Chanez P., Bousquet J., Crastes d.P., Michel F.B., and Godard P. Enhanced alveolar cell luminal-dependent chemiluminescence in asthma. J Allergy Clin Immunol 80 (1987) 195-201
41. Comhair S.A., Bhathena P.R., Dweik R.A., Kavuru M., and Erzurum S.C. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 355 (2000) 624
42. Comhair S.A., Ricci K.S., Arroliga M., Lara A.R., Dweik R.A., Song W., et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 172 (2005) 306-313
43. Comhair S.A., Xu W., Ghosh S., Thunnissen F.B., Almasan A., Calhoun W.J., et al. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol 166 (2005) 663-674
44. Cortijo J., Marti-Cabrera M., de la Asuncion J.G., Pallardo F.V., Esteras A., Bruseghini L., et al. Contraction of human airways by oxidative stress protection by N-acetylcysteine. Free Radic Biol Med 27 (1999) 392-400
45. Cosio B.G., Mann B., Ito K., Jazrawi E., Barnes P.J., Chung K.F., et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med 170 (2004) 141-147
46. Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., and Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200 (2004) 689-695
47. Cress W.D., and Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184 (2000) 1-16
48. Cross C.E., O'Neill V., Louie C.A., and Halliwell S. Oxidants, antioxidants, and respiratory tract lining fluids. Environ Health Perspect 102 Suppl. 10 (1994) 185-191
49. Culpitt S.V., Rogers D.F., Fenwick P.S., Shah P., De Matos C., Russell R.E., et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58 (2003) 942-946
50. Cuzzocrea S., Thiemermann C., and Salvemini D. Potential therapeutic effect of antioxidant therapy in shock and inflammation. Curr Med Chem 11 (2004) 1147-1162
51. Datta K., Babbar P., Srivastava T., Sinha S., and Chattopadhyay P. P53 dependent apoptosis in glioma cell lines in response to hydrogen peroxide induced oxidative stress. Int J Biochem Cell Biol 34 (2002) 148-157
52. Day B.J. Catalytic antioxidants: a radical approach to new therapeutics. Drug Discov Today 9 (2004) 557-566
53. De Benedetto F., Aceto A., Dragani B., Spacone A., Formisano S., Pela R., et al. Long-term oral N-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm Pharmacol Ther 18 (2005) 41-47
54. Decramer M., Rutten-van Molken M., Dekhuijzen P.N., Troosters T., van Herwaarden C., Pellegrino R., et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial. Lancet 365 (2005) 1552-1560
55. Dekhuijzen P.N. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J 23 (2004) 629-636
56. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154 (1996) 813-816
57. Doctrow S.R., Huffman K., Marcus C.B., Musleh W., Bruce A., Baudry M., et al. Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv Pharmacol 38 (1997) 247-269
58. Dohlman A.W., Black H.R., and Royall J.A. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 148 (1993) 955-960
59. Donaldson K., Brown D.M., Mitchell C., Dineva M., Beswick P.H., Gilmour P., et al. Free radical activity of PM10: iron-mediated generation of hydroxyl radicals. Environ Health Perspect 105 Suppl. 5 (1997) 1285-1289
60. Donnelly L.E., Newton R., Kennedy G.E., Fenwick P.S., Leung R.H., Ito K., et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol 287 (2004) L774-L783
61. Drath D.B., Karnovsky M.L., and Huber G.L. The effects of experimental exposure to tobacco smoke on the oxidative metabolism of alveolar macrophages. J Reticuloendothel Soc 25 (1979) 597-604
62. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223 (2005) 181-190
63. Dweik R.A., Comhair S.A., Gaston B., Thunnissen F.B., Farver C., Thomassen M.J., et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci U S A 98 (2001) 2622-2627
64. Dworski R. Oxidant stress in asthma. Thorax 55 Suppl. 2 (2000) S51-S53
65. Dworski R., Murray J.J., Roberts L.J., Oates J.A., Morrow J.D., Fisher L., et al. Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med 160 (1999) 1947-1951
66. Dworski R., Roberts L.J., Murray J.J., Morrow J.D., Hartert T.V., and Sheller J.R. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-Iso-PGF2alpha). Clin Exp Allergy 31 (2001) 387-390
67. Exner M., Minar E., Wagner O., and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37 (2004) 1097-1104
68. Fahn H.J., Wang L.S., Kao S.H., Chang S.C., Huang M.H., and Wei Y.H. Smoking-associated mitochondrial DNA mutations and lipid peroxidation in human lung tissues. Am J Respir Cell Mol Biol 19 (1998) 901-909
69. Filomeni G., Rotilio G., and Ciriolo M.R. Cell signalling and the glutathione redox system. Biochem Pharmacol 64 (2002) 1057-1064
70. Fiorini G., Crespi S., Rinaldi M., Oberti E., Vigorelli R., and Palmieri G. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. Biomed Pharmacother 54 (2000) 274-278
71. Fogarty A., Lewis S.A., Scrivener S.L., Antoniak M., Pacey S., Pringle M., et al. Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial. Clin Exp Allergy 33 (2003) 1355-1359
72. Foreman R.C., Mercer P.F., Kroegel C., and Warner J.A. Role of the eosinophil in protein oxidation in asthma: possible effects on proteinase/antiproteinase balance. Int Arch Allergy Immunol 118 (1999) 183-186
73. Foster M.W., McMahon T.J., and Stamler J.S. S-nitrosylation in health and disease. Trends Mol Med 9 (2003) 160-168
74. Gaston B., Sears S., Woods J., Hunt J., Ponaman M., McMahon T., et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351 (1998) 1317-1319
75. Ghio A.J., Pritchard R.J., Dittrich K.L., and Samet J.M. Non-heme (Fe3+) in the lung increases with age in both humans and rats. J Lab Clin Med 129 (1997) 53-61
76. Gilks C.B., Price K., Wright J.L., and Churg A. Antioxidant gene expression in rat lung after exposure to cigarette smoke. Am J Pathol 152 (1998) 269-278
77. Gilliland F.D., Berhane K.T., Li Y.F., Gauderman W.J., McConnell R., and Peters J. Children's lung function and antioxidant vitamin, fruit, juice, and vegetable intake. Am J Epidemiol 158 (2003) 576-584
78. Gillissen A., Roum J.H., Hoyt R.F., and Crystal R.G. Aerosolization of superoxide dismutase. augmentation of respiratory epithelial lining fluid antioxidant screen by aerosolization of recombinant human Cu++/Zn++ superoxide dismutase. Chest 104 (1993) 811-815
79. Gillissen A., Jaworska M., Orth M., Coffiner M., Maes P., App E.M., et al. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro. Respir Med 91 (1997) 159-168
80. Gompertz S., Bayley D.L., Hill S.L., and Stockley R.A. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related, COPD. Thorax 56 (2001) 36-41
81. Grootveld M., and Halliwell B. Measurement of allantoin and uric acid in human body fluids. A Potential index of free-radical reactions in vivo?. Biochem J 243 (1987) 803-808
82. Groves J.T. Peroxynitrite: reactive, invasive and enigmatic. Curr Opin Chem Biol 3 (1999) 226-235
83. Grundemann D., Harlfinger S., Golz S., Geerts A., Lazar A., Berkels R., et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 102 (2005) 5256-5261
84. Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 41 (1995) 1819-1828
85. Gutteridge J.M., and Halliwell B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899 (2000) 136-147
86. Guyton K.Z., Liu Y., Gorospe M., Xu Q., and Holbrook N.J. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271 (1996) 4138-4142
87. Haddad E., McCluskie K., Birrell M.A., Dabrowski D., Pecoraro M., Underwood S., et al. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation. J Immunol 169 (2002) 974-982
88. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic Res 25 (1996) 439-454
89. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186 (1990) 1-85
90. Halliwell B., and Gutteridge J.M. The antioxidants of human extracellular fluids. Arch Biochem Biophys 280 (1990) 1-8
91. Halliwell B., and Gutteridge J.M. Free Radicals in Biology and Medicine. 3rd ed. (1999), Oxford University Press, New York
92. Hanazawa T., Kharitonov S.A., and Barnes P.J. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 162 (2000) 1273-1276
93. Hand C.E., Taylor N.J., and Honek J.F. Ab initio studies of the properties of intracellular thiols ergothioneine and ovothiol. Bioorg Med Chem Lett 15 (2005) 1357-1360
94. Harik-Khan R.I., Muller D.C., and Wise R.A. Serum vitamin levels and the risk of asthma in children. Am J Epidemiol 159 (2004) 351-357
95. Harju T., Kaarteenaho-Wiik R., Soini Y., Sormunen R., and Kinnula V.L. Diminished immunoreactivity of gamma-glutamylcysteine synthetase in the airways of smokers' lung. Am J Respir Crit Care Med 166 (2002) 754-759
96. Harrison D.J., Cantlay A.M., Rae F., Lamb D., and Smith C.A. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Human Exp Toxicol 16 (1997) 356-360
97. Hatch G.E. Asthma, inhaled oxidants, and dietary antioxidants. Am J Clin Nutr 61 (1995) 625S-630S
98. Henderson W.R., Chi E.Y., Teo J.L., Nguyen C., and Kahn M. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model. J Immunol 169 (2002) 5294-5299
99. Hiltermann T.J., Peters E.A., Alberts B., Kwikkers K., Borggreven P.A., Hiemstra P.S., et al. Ozone-induced airway hyperresponsiveness in patients with asthma: role of neutrophil-derived serine proteinases. Free Radic Biol Med 24 (1998) 952-958
100. Hogg N., and Kalyanaraman B. Nitric oxide and lipid peroxidation. Biochim Biophys Acta 1411 (1999) 378-384
101. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
102. Huang R.P., Peng A., Hossain M.Z., Fan Y., Jagdale A., and Boynton A.L. Tumor promotion by hydrogen peroxide in rat liver epithelial cells. Carcinogenesis 20 (1999) 485-492
103. Hulsmann A.R., Raatgeep H.R., den Hollander J.C., Stijnen T., Saxena P.R., Kerrebijn K.F., et al. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med 149 (1994) 519-525
104. Ichiki T., Tokunou T., Fukuyama K., Iino N., Masuda S., and Takeshita A. Cyclic AMP response element-binding protein mediates reactive oxygen species-induced C-fos expression. Hypertension 42 (2003) 177-183
105. Ichinose M., Sugiura H., Yamagata S., Koarai A., and Shirato K. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med 162 (2000) 701-706
106. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 Inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 20 (2000) 6891-6903
107. Ito K., Hanazawa T., Tomita K., Barnes P.J., and Adcock I.M. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 315 (2004) 240-245
108. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352 (2005) 1967-1976
109. Izumi M., McDonald M.C., Sharpe M.A., Chatterjee P.K., and Thiemermann C. Superoxide dismutase mimetics with catalase activity reduce the organ injury in hemorrhagic shock. Shock 18 (2002) 230-235
110. Janoff A., Pryor W.A., and Bengali Z.H. NHLBI workshop summary. Effects of tobacco smoke components on cellular and biochemical processes in the lung. Am Rev Respir Dis 136 (1987) 1058-1064
111. Janssen-Heininger Y., Ckless K., Reynaert N., and vand V. SOD inactivation in asthma: bad or no news?. Am J Pathol 166 (2005) 649-652
112. Jeffery P.K. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53 (1998) 129-136
113. Jobin C., Bradham C.A., Russo M.P., Juma B., Narula A.S., Brenner D.A., et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163 (1999) 3474-3483
114. Jozsef L., and Filep J.G. Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. Free Radic Biol Med 35 (2003) 1018-1027
115. Kamata H., Honda S., Maeda S., Chang L., Hirata H., and Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120 (2005) 649-661
116. Kaminsky D.A., Mitchell J., Carroll N., James A., Soultanakis R., and Janssen Y. Nitrotyrosine formation in the airways and lung parenchyma of patients with asthma. J Allergy Clin Immunol 104 (1999) 747-754
117. Kanazawa H., Kurihara N., Hirata K., and Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest 100 (1991) 1319-1322
118. Kang J., Chen J., Shi Y., Jia J., and Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 69 (2005) 1205-1213
119. Kinsella B.T., O'Mahony D.J., and Fitzgerald G.A. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther 281 (1997) 957-964
120. Kirkham P.A., Spooner G., Ffoulkes-Jones C., and Calvez R. Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 35 (2003) 697-710
121. Kirkham P.A., Spooner G., Rahman I., and Rossi A.G. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun 318 (2004) 32-37
122. Knekt P., Kumpulainen J., Jarvinen R., Rissanen H., Heliovaara M., Reunanen A., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76 (2002) 560-568
123. Krishna M.T., Madden J., Teran L.M., Biscione G.L., Lau L.C., Withers N.J., et al. Effects of 0.2 Ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J 11 (1998) 1294-1300
124. Lacoste J.Y., Bousquet J., Chanez P., Van Vyve T., Simony-Lafontaine J., Lequeu N., et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 92 (1993) 537-548
125. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., et al. A molecular redox switch on P21(Ras). Structural basis for the nitric oxide-P21(Ras) interaction. J Biol Chem 272 (1997) 4323-4326
126. Lapenna D., de Gioia S., Mezzetti A., Ciofani G., Consoli A., Marzio L., et al. Cigarette smoke, ferritin, and lipid peroxidation. Am J Respir Crit Care Med 151 (1995) 431-435
127. Lebowitz M.D., Postma D.S., and Burrows B. Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis. Chest 108 (1995) 55-61
128. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., et al. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 87 (2000) 516-521
129. Lee S.L., Simon A.R., Wang W.W., and Fanburg B.L. H2O2 signals 5-ht-induced erk map kinase activation and mitogenesis of smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 281 (2001) L646-L652
130. Leitinger N., Tyner T.R., Oslund L., Rizza C., Subbanagounder G., Lee H., et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci U S A 96 (1999) 12010-12015
131. Li X.Y., Donaldson K., Rahman I., and MacNee W. An investigation of the role of glutathione in increased epithelial permeability induced by cigarette smoke in vivo and in vitro. Am J Respir Crit Care Med 149 (1994) 1518-1525
132. Li Y., Liu W., Xing G., Tian C., Zhu Y., and He F. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB. Cell Signal 17 (2005) 985-996
133. Liu L., and Stamler J.S. NO: an inhibitor of cell death. Cell Death Differ 6 (1999) 937-942
134. MacNee W., and Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) S58-S65
135. MacNee W., Bridgeman M.M., Marsden M., Drost E., Lannan S., Selby C., and Donaldson K. The effects of N-acetylcysteine and glutathione on smoke-induced changes in lung phagocytes and epithelial cells. Am J Med 91 (1991) 60S-66S
136. Mai A., Massa S., Rotili D., Cerbara I., Valente S., Pezzi R., et al. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Med Res Rev 25 (2005) 261-309
137. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164 (2000) 6509-6519
138. Marwick J.A., Kirkham P.A., Stevenson C.S., Danahay H., Giddings J., Butler K., et al. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31 (2004) 633-642
139. Mateos F., Brock J.H., and Perez-Arellano J.L. Iron metabolism in the lower respiratory tract. Thorax 53 (1998) 594-600
140. McBride D.E., Koenig J.Q., Luchtel D.L., Williams P.V., and Henderson Jr. W.R. Inflammatory effects of ozone in the upper airways of subjects with asthma. Am J Respir Crit Care Med 149 (1994) 1192-1197
141. Mezzetti A., Lapenna D., Pierdomenico S.D., Calafiore A.M., Costantini F., Riario-Sforza G., et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 112 (1995) 91-99
142. Mitra S.N., Slungaard A., and Hazen S.L. Role of eosinophil peroxidase in the origins of protein oxidation in asthma. Redox Rep 5 (2000) 215-224
143. Montuschi P., Collins J.V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S.A., et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162 (2000) 1175-1177
144. Moodie F.M., Marwick J.A., Anderson C.S., Szulakowski P., Biswas S.K., Bauter M.R., et al. Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. FASEB J 18 (2004) 1897-1899
145. Moretti M., Bottrighi P., Dallari R., Da P.R., Dolcetti A., Grandi P., et al. The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE study. Drugs Exp Clin Res 30 (2004) 143-152
146. Morrison D., Rahman I., Lannan S., and MacNee W. Epithelial permeability, inflammation, and oxidant stress in the air spaces of smokers. Am J Respir Crit Care Med 159 (1999) 473-479
147. Morrow J.D., and Roberts L.J. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36 (1997) 1-21
148. Morrow J.D., Frei B., Longmire A.W., Gaziano J.M., Lynch S.M., Shyr Y., et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. smoking as a cause of oxidative damage. N Engl J Med 332 (1995) 1198-1203
149. Muscoli C., Sacco I., Alecce W., Palma E., Nistico R., Costa N., et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther 311 (2004) 44-50
150. Nadeem A., Raj H.G., and Chhabra S.K. Increased oxidative stress in acute exacerbations of asthma. J Asthma 42 (2005) 45-50
151. Nakashima H., Ando M., Sugimoto M., Suga M., Soda K., and Araki S. Receptor-mediated O2- release by alveolar macrophages and peripheral blood monocytes from smokers and nonsmokers. priming and triggering effects of monomeric IgG, concanavalin A, N-formyl-methionyl-leucyl-phenylalanine, phorbol myristate acetate, and cytochalasin D. Am Rev Respir Dis 136 (1987) 310-315
152. Nakayama T., Church D.F., and Pryor W.A. Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med 7 (1989) 9-15
153. Neurohr C., Lenz A.G., Ding I., Leuchte H., Kolbe T., and Behr J. Glutamate-cysteine ligase modulatory subunit in BAL alveolar macrophages of healthy smokers. Eur Respir J 22 (2003) 82-87
154. Nguyen C., Teo J.L., Matsuda A., Eguchi M., Chi E.Y., Henderson Jr. W.R., et al. Chemogenomic identification of ref-1/AP-1 as a therapeutic target for asthma. Proc Natl Acad Sci U S A 100 (2003) 1169-1173
155. Nowak D., Antczak A., Krol M., Pietras T., Shariati B., Bialasiewicz P., et al. Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J 9 (1996) 652-657
156. Nowak D., Kasielski M., Pietras T., Bialasiewicz P., and Antczak A. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis 53 (1998) 268-273
157. Nowak D., Kasielski M., Antczak A., Pietras T., and Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 93 (1999) 389-396
158. Okamoto K., Tanaka H., Ogawa H., Makino Y., Eguchi H., Hayashi S., et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274 (1999) 10363-10371
159. Okazawa A., Kawikova I., Cui Z.H., Skoogh B.E., and Lotvall J. 8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 155 (1997) 436-441
160. Owen S., Pearson D., Suarez-Mendez V., O'Driscoll R., and Woodcock A. Evidence of free-radical activity in asthma. N Engl J Med 325 (1991) 586-587
161. Parola M., Bellomo G., Robino G., Barrera G., and Dianzani M.U. 4-hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1 (1999) 255-284
162. Pearson P.J., Lewis S.A., Britton J., and Fogarty A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax 59 (2004) 652-656
163. Petruzzelli S., Puntoni R., Mimotti P., Pulera N., Baliva F., Fornai E., et al. Plasma 3-nitrotyrosine in cigarette smokers. Am J Respir Crit Care Med 156 (1997) 1902-1907
164. Pignatelli B., Li C.Q., Boffetta P., Chen Q., Ahrens W., Nyberg F., et al. Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res 61 (2001) 778-784
165. Poli G., Leonarduzzi G., Biasi F., and Chiarpotto E. Oxidative stress and cell signalling. Curr Med Chem 11 (2004) 1163-1182
166. Pratico D., Basili S., Vieri M., Cordova C., Violi F., and Fitzgerald G.A. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med 158 (1998) 1709-1714
167. Pryor W.A., and Stone K. Oxidants in cigarette smoke. radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 686 (1993) 12-27
168. Qin J., Clore G.M., Kennedy W.M., Huth J.R., and Gronenborn A.M. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF Kappa B. Structure 3 (1995) 289-297
169. Rahman I., and MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med 21 (1996) 669-681
170. Rahman I., and MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 53 (1998) 601-612
171. Rahman I., and MacNee W. Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 277 (1999) L1067-L1088
172. Rahman I., and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16 (2000) 534-554
173. Rahman I., Bel A., Mulier B., Lawson M.F., Harrison D.J., MacNee W., et al. Transcriptional regulation of gamma-glutamylcysteine synthetase-heavy subunit by oxidants in human alveolar epithelial cells. Biochem Biophys Res Commun 229 (1996) 832-837
174. Rahman I., Morrison D., Donaldson K., and MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154 (1996) 1055-1060
175. Rahman I., Smith C.A., Lawson M.F., Harrison D.J., and MacNee W. Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett 396 (1996) 21-25
176. Rahman I., van Schadewijk A.A., Hiemstra P.S., Stolk J., van Krieken J.H., MacNee W., et al. Localization of gamma-glutamylcysteine synthetase messenger rna expression in lungs of smokers and patients with chronic obstructive pulmonary disease. Free Radic Biol Med 28 (2000) 920-925
177. Rahman I., van Schadewijk A.A., Crowther A.J., Hiemstra P.S., Stolk J., MacNee W., et al. 4-hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 490-495
178. Rahman I., Gilmour P.S., Jimenez L.A., Biswas S.K., Antonicelli F., and Aruoma O.I. Ergothioneine inhibits oxidative stress- and TNF-alpha-induced NF-kappa B activation and interleukin-8 release in alveolar epithelial cells. Biochem Biophys Res Commun 302 (2003) 860-864
179. Rahman I., Marwick J., and Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation. NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68 (2004) 1255-1267
180. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114 (2004) 1248-1259
181. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., and Fryer A.D. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202 (2005) 47-59
182. Rautalahti M., Virtamo J., Haukka J., Heinonen O.P., Sundvall J., Albanes D., et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am J Respir Crit Care Med 156 (1997) 1447-1452
183. Reilly M., Delanty N., Lawson J.A., and Fitzgerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94 (1996) 19-25
184. Repine J.E., Bast A., and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative stress study group. Am J Respir Crit Care Med 156 (1997) 341-357
185. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271 (1995) 67-74
186. Rochelle L.G., Fischer B.M., and Adler K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic Biol Med 24 (1998) 863-868
187. Romieu I., and Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 23 (2001) 268-287
188. Rubin R.N., Navon L., and Cassano P.A. Relationship of serum antioxidants to asthma prevalence in youth. Am J Respir Crit Care Med 169 (2004) 393-398
189. Sadeghi-Hashjin G., Folkerts G., Henricks P.A., Verheyen A.K., van der Linde H.J., van A., et al. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am J Respir Crit Care Med 153 (1996) 1697-1701
190. Sadowska A.M., van Overveld F.J., Gorecka D., Zdral A., Filewska M., Demkow U.A., et al. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Respir Med 99 (2005) 241-249
191. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) S17-S20
192. Saetta M., Turato G., Maestrelli P., Mapp C.E., and Fabbri L.M. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1304-1309
193. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17 (1998) 2596-2606
194. Salvemini D., Wang Z.Q., Zweier J.L., Samouilov A., Macarthur H., Misko T.P., et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 286 (1999) 304-306
195. Sanders S.P., Zweier J.L., Harrison S.J., Trush M.A., Rembish S.J., and Liu M.C. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med 151 (1995) 1725-1733
196. Santos M.C., Oliveira A.L., Viegas-Crespo A.M., Vicente L., Barreiros A., Monteiro P., et al. Systemic markers of the redox balance in chronic obstructive pulmonary disease. Biomarkers 9 (2004) 461-469
197. Santus P., Sola A., Carlucci P., Fumagalli F., Di G.A., Mondoni M., et al. Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 838-843
198. Schauer U., Leinhaas C., Jager R., and Rieger C.H. Enhanced superoxide generation by eosinophils from asthmatic children. Int Arch Allergy Appl Immunol 96 (1991) 317-321
199. Schorah C.J., Downing C., Piripitsi A., Gallivan L., Al-Hazaa A.H., Sanderson M.J., et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically Ill patients. Am J Clin Nutr 63 (1996) 760-765
200. Schwartz J., and Weiss S.T. Relationship between dietary vitamin C intake and pulmonary function in the first national health and nutrition examination survey (NHANES I). Am J Clin Nutr 59 (1994) 110-114
201. Sedgwick J.B., Geiger K.M., and Busse W.W. Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis 142 (1990) 120-125
202. Seltzer J., Bigby B.G., Stulbarg M., Holtzman M.J., Nadel J.A., Ueki I.F., et al. O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 60 (1986) 1321-1326
203. Sen C.K. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55 (1998) 1747-1758
204. Sharpe M.A., Ollosson R., Stewart V.C., and Clark J.B. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J 366 (2002) 97-107
205. Shi H., Timmins G., Monske M., Burdick A., Kalyanaraman B., Liu Y., et al. Evaluation of spin trapping agents and trapping conditions for detection of cell-generated reactive oxygen species. Arch Biochem Biophys 437 (2005) 59-68
206. Shishodia S., Potdar P., Gairola C.G., and Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24 (2003) 1269-1279
207. Silkoff P.E., Sylvester J.T., Zamel N., and Permutt S. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 161 (2000) 1218-1228
208. Simic M.G., and Jovanovic S.V. Antioxidation mechanisms of uric acid. J Am Chem Soc 111 15 (1989) 5778-5782 (Ref Type: Journal (Full)
209. Smith L.J., Houston M., and Anderson J. Increased levels of glutathione in bronchoalveolar lavage fluid from patients with asthma. Am Rev Respir Dis 147 (1993) 1461-1464
210. Smith L.J., Shamsuddin M., Sporn P.H., Denenberg M., and Anderson J. Reduced superoxide dismutase in lung cells of patients with asthma. Free Radic Biol Med 22 (1997) 1301-1307
211. Smith K.R., Uyeminami D.L., Kodavanti U.P., Crapo J.D., Chang L.Y., and Pinkerton K.E. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic Biol Med 33 (2002) 1106-1114
212. Snider G.L. Chronic obstructive pulmonary disease: risk factors. Pathophysiology and pathogenesis. Annu Rev Med 40 (1989) 411-429
213. Spencer J.P., Jenner A., Chimel K., Aruoma O.I., Cross C.E., Wu R., et al. DNA damage in human respiratory tract epithelial cells: damage by gas phase cigarette smoke apparently involves attack by reactive nitrogen species in addition to oxygen radicals. FEBS Lett 375 (1995) 179-182
214. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
215. Su W.Y., Folz R., Chen J.S., Crapo J.D., and Chang L.Y. Extracellular superoxide dismutase MRNA expressions in the human lung by in situ hybridization. Am J Respir Cell Mol Biol 16 (1997) 162-170
216. Sun Y., and Oberley L.W. Redox regulation of transcriptional activators. Free Radic Biol Med 21 (1996) 335-348
217. Tabak C., Arts I.C., Smit H.A., Heederik D., and Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN study. Am J Respir Crit Care Med 164 (2001) 61-64
218. Teramoto S., Shu C.Y., Ouchi Y., and Fukuchi Y. Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J Asthma 33 (1996) 149-155
219. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279 (2000) L1005-L1028
220. Thompson A.B., Bohling T., Heires A., Linder J., and Rennard S.I. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med 117 (1991) 493-499
221. Tsukagoshi H., Shimizu Y., Iwamae S., Hisada T., Ishizuka T., Iizuka K., et al. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline. Respir Med 94 (2000) 584-588
222. Tuder R.M., Zhen L., Cho C.Y., Taraseviciene-Stewart L., Kasahara Y., Salvemini D., et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29 (2003) 88-97
223. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y., and Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274 (1999) 2234-2242
224. Vachier I., Damon M., Le D.C., de Paulet A.C., Chanez P., Michel F.B., et al. Increased oxygen species generation in blood monocytes of asthmatic patients. Am Rev Respir Dis 146 (1992) 1161-1166
225. van d. V., Smith D., O'Neill C.A., Kaur H., rley-Usmar V., Cross C.E., et al. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion. Biochem J 303 Pt 1 (1994) 295-301
226. Walda I.C., Tabak C., Smit H.A., Rasanen L., Fidanza F., Menotti A., et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr 56 (2002) 638-643
227. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., and Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137 (1988) 62-69
228. Wesselius L.J., Nelson M.E., and Skikne B.S. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med 150 (1994) 690-695
229. Wu W., Samoszuk M.K., Comhair S.A., Thomassen M.J., Farver C.F., Dweik R.A., et al. Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 105 (2000) 1455-1463
230. Yeh M., Leitinger N., de M.R., Onai N., Matsushima K., Vora D.K., et al. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler Thromb Vasc Biol 21 (2001) 1585-1591
231. Zang L.Y., Stone K., and Pryor W.A. Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance. Free Radic Biol Med 19 (1995) 161-167
232. Zhang P., Wang Y.Z., Kagan E., and Bonner J.C. Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275 (2000) 22479-22486
233. Zhang M., Nomura A., Uchida Y., Iijima H., Sakamoto T., Iishii Y., et al. Ebselen suppresses late airway responses and airway inflammation in guinea pigs. Free Radic Biol Med 32 (2002) 454-464
234. Zimmerman M.C., Lazartigues E., Lang J.A., Sinnayah P., Ahmad I.M., Spitz D.R., et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91 (2002) 1038-1045